IL-6 blockade was achieved by transferring neuromyelitis optica immunoglobulin G (NMO-IgG) autoantibodies and satralizumab through the BBB using a triple culture system, which mimics the close contact of endothelial cells, pericytes, and astrocyte processes [183]. Here, IL6 is linked to neuromyelitis optica.